Kawasaki Disease – Swollen Hands and Feet

What is Kawasaki Disease Swollen Hands/Feet?

Kawasaki disease (KD) is an acute, self‑limited vasculitis that primarily affects children under 5 years of age. One of the hallmark early signs is **painful swelling of the hands and feet**, often accompanied by redness (erythema) and a “peeling” of the skin that appears a week or two later. The swelling usually starts in the fingers and toes, may spread to the palms and soles, and can be so pronounced that the child’s hands or feet look puffy like “balloon‑like” tips.

Although the exact trigger for KD is still unknown, the disease can cause inflammation of medium‑size arteries throughout the body, most importantly the coronary arteries that supply the heart. Early recognition of the swelling sign—along with fever persisting for ≥ 5 days—is crucial because prompt treatment reduces the risk of serious heart complications.

Common Causes

Swollen hands and feet are not unique to Kawasaki disease. Below are 8–10 other conditions that can produce similar findings. Understanding the differential helps clinicians decide when the swelling is likely KD versus another illness.

• Viral exanthems – Parvovirus B19, enteroviruses, and adenovirus can cause hand‑foot‑mouth disease with edema.
• Streptococcal or staphylococcal infections – Cellulitis or scarlet fever may produce localized swelling and redness.
• Rheumatic fever – An autoimmune reaction to streptococcal infection that can cause joint swelling, including the hands and feet.
• Juvenile idiopathic arthritis (JIA) – Especially the systemic or polyarticular forms, which present with symmetric joint swelling.
• Henoch‑Schönlein purpura (IgA vasculitis) – Small‑vessel vasculitis that can cause edema of the feet and ankles.
• Hand‑foot‑mouth disease (coxsackievirus A16) – Classic for toddlers; swelling precedes the characteristic vesicular rash.
• Scarlet fever (streptococcal infection) – “Strawberry tongue” and swollen extremities may mimic early KD.
• Allergic reactions – Acute urticaria or serum‑sickness–type reactions can lead to generalized edema.
• Congenital or acquired lymphedema – Chronic swelling; usually non‑painful but can be confused with KD in older children.
• Systemic lupus erythematosus (SLE) – In rare pediatric cases, vasculitic flares may cause hand/foot swelling.

Associated Symptoms

In Kawasaki disease, swelling seldom occurs in isolation. The following signs are commonly observed alongside the puffiness of the hands and feet:

• Prolonged high fever – Typically > 38.5 °C (101.3 °F) lasting ≥ 5 days.
• Conjunctival injection – Bright red eyes without discharge.
• Oral changes – “Strawberry” or cracked tongue, red cracked lips.
• Polymorphous rash – Often starts on the trunk and spreads to the extremities.
• Swollen cervical lymph nodes – Usually unilateral and > 1.5 cm in diameter.
• Skin peeling (desquamation) – Begins around nails and fingertips 1–2 weeks after fever onset.
• Joint pain (arthralgia) or mild arthritis – Typically non‑erosive and resolves with disease.
• irritability or lethargy – Particularly in infants who cannot verbalize discomfort.

When to See a Doctor

Because KD can lead to coronary artery aneurysms in up to 25 % of untreated cases, early medical evaluation is essential. Seek pediatric or urgent‑care assessment if a child presents with any of the following:

• Fever lasting ≥ 5 days without an obvious source.
• Swelling **and** redness of the hands or feet, especially if painful.
• Two or more of the classic KD signs listed above (conjunctivitis, oral changes, rash, lymphadenopathy).
• Sudden onset of unexplained swelling after a viral illness.
• Any concern for heart involvement—chest pain, shortness of breath, or palpitations.

When in doubt, err on the side of caution and have the child evaluated by a health professional.

Diagnosis

There is no single laboratory test that confirms Kawasaki disease. Diagnosis relies on a combination of clinical criteria, lab findings, and imaging.

Clinical criteria

1. Fever ≥ 5 days plus ≥ four of the five principal features (conjunctivitis, oral changes, extremity changes, rash, cervical lymphadenopathy).
2. If incomplete KD is suspected (fewer than four features), additional laboratory or echocardiographic evidence is required.

Laboratory studies

• Elevated inflammatory markers – C‑reactive protein (CRP) > 3 mg/dL, erythrocyte sedimentation rate (ESR) > 40 mm/hr.
• Complete blood count – Often reveals leukocytosis (high white‑blood‑cell count), anemia, and thrombocytosis (platelets > 450 × 10⁹/L) in the sub‑acute phase.
• Urine analysis – May show sterile pyuria (white cells without bacteria).
• Serum electrolytes and liver enzymes – Mild transaminitis can be present.

Imaging

• Echocardiogram – First‑line cardiac imaging to assess coronary artery dimensions, aneurysms, or myocarditis. Recommended at diagnosis and repeated at 2‑weeks and 6‑weeks.
• Electrocardiogram (ECG) – May show nonspecific ST‑T changes.
• Chest X‑ray – Typically normal but can help rule out pneumonia if respiratory symptoms co‑exist.

Differential diagnosis

Clinicians compare the presentation with the list of other causes (viral exanthems, bacterial infections, JIA, etc.) and may order throat cultures, viral PCR panels, or rheumatologic panels to exclude alternatives.

Treatment Options

The goal of therapy is to reduce inflammation, relieve symptoms, and most importantly, prevent coronary artery damage.

First‑line medical therapy

• Intravenous immunoglobulin (IVIG) – 2 g/kg single infusion over 10–12 hours. Administered within the first 10 days of fever, it reduces the risk of aneurysm from ~25 % to < 5 % when given promptly.¹
• Aspirin – High‑dose (80–100 mg/kg/day) during the acute phase, then low‑dose (3–5 mg/kg/day) for antiplatelet effect until the 6‑week echo is normal.

Adjunctive therapies (for IVIG‑resistant cases)

• Second dose of IVIG – Given if fever persists > 36 hours after the first infusion.
• Corticosteroids – Methylprednisolone (2 mg/kg/day) or pulse therapy (30 mg/kg) can be added, especially in high‑risk patients.
• Infliximab (anti‑TNFα) or abatacept – Considered for refractory disease in specialist centers.

Supportive and home care measures

• Keep the child well‑hydrated; fever can increase fluid loss.
• Comfort measures for swollen hands/feet – cool, moist compresses can lessen discomfort.
• Soft, easy‑to‑eat foods if mouth is sore.
• Monitor temperature every 4–6 hours; keep a fever diary for the physician.

Follow‑up

Regular cardiology follow‑up is essential. Most children normalize coronary dimensions within 6‑8 weeks, but some require long‑term monitoring (up to 10 years) if aneurysms persist.

Prevention Tips

Because the exact trigger of Kawasaki disease is unknown, primary prevention is challenging. However, general measures can reduce the likelihood of infections that might act as a catalyst:

• Practice good hand hygiene—wash hands with soap for ≥ 20 seconds.
• Keep up‑to‑date with routine childhood vaccinations (influenza, pneumococcal, etc.).
• Avoid close contact with individuals who have active viral or bacterial respiratory infections.
• Maintain a healthy diet rich in fruits, vegetables, and omega‑3 fatty acids to support immune function.
• Seek prompt medical care for prolonged fevers or unexplained swelling.

Emergency Warning Signs

Key Take‑aways

• Kawasaki disease is a pediatric vasculitis where swollen, painful hands and feet are an early clue.
• Diagnosis rests on fever lasting ≥ 5 days plus classic clinical signs, supported by labs and an echocardiogram.
• Prompt treatment with IVIG and aspirin dramatically lowers the risk of heart complications.
• Parents should seek medical evaluation for any child with prolonged fever and extremity swelling, and act quickly if emergency warning signs develop.

---

References: 1. Newburger JW, et al. “Diagnosis, Treatment, and Long‑Term Management of Kawasaki Disease.” Circulation. 2020;141:e126‑e133. 2. McCrindle BW, et al. “Kawasaki Disease.” Mayo Clinic Proceedings. 2021;96(8):1825‑1838. 3. CDC. “Kawasaki Disease.” 2023. https://www.cdc.gov/kawasaki/